Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.45 |
| ▸ | NQO2 | P16083 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | ACP3 | P15309 | 1/20 | 0.43 |
| ▸ | DAO | P14920 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CDYL | Q9Y232 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29825535 | 1.00 | CYP1A2 (0.46) | CYP1A2CYP2C19CYP2D6MTNR1ANQO2 | |
| SCHEMBL7104796 | 0.92 | CYP1A2 (0.44) | CYP1A2CYP2C19CYP2D6MTNR1ANQO2 | |
| SCHEMBL11431707 | 0.90 | CYP1A2 (0.43) | CYP1A2CYP2C19CYP2D6MTNR1ANQO2 | |
| SCHEMBL3720960 | 0.85 | KDM4E (0.37) | CYP1A2MTNR1ANQO2DAOALDH1A1 | |
| SCHEMBL18204484 | 0.85 | L3MBTL1 (0.39) | CYP1A2CYP2C19CYP2D6MTNR1ANQO2 | |
| SCHEMBL29846915 | 0.82 | MIF (0.39) | — | |
| SCHEMBL111243 | 0.82 | MIF (0.39) | — | |
| SCHEMBL7525986 | 0.82 | KEAP1 (0.53) | CYP1A2CYP2C19CYP2D6MTNR1ANQO2 | |
| SCHEMBL1848951 | 0.81 | CYP1A2 (0.48) | CYP1A2CYP2C19CYP2D6MTNR1ANQO2 | |
| SCHEMBL3713612 | 0.79 | KMT2A (0.54) | CYP1A2CYP2D6TDP1MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 375 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116217444-A | Photo-generated chiral radical molecule with circularly polarized luminescence property based on triarylamine derivative | 中国科学院化学研究所 | 2023-06-06 | — | — | CN | claimed |
| CN-115243789-A | Catalyst composition for polyurethane | 迈图高新材料公司 | 2022-10-25 | — | — | CN | claimed |
| CN-115210283-A | Catalysts for polyurethane formation | 迈图高新材料公司 | 2022-10-18 | — | — | CN | claimed |
| EP-3612581-B1 | CATALYSTS FOR PRODUCING POLYURETHANES | MOMENTIVE PERFORMANCE MAT GMBH (DE) | 2020-12-23 | — | — | EP | claimed |
| CN-110891994-A | Catalyst for producing polyurethane | 莫门蒂夫性能材料有限公司 | 2020-03-17 | — | — | CN | claimed |
| WO-2010112946-A1 | ADAMANTANE BISUREA DERIVATIVES, METHOD OF PREPARATION AND APPLICATION IN ANION SENSING | RUDJER BOSKOVIC INSTITUTE (HR) | 2010-10-07 | — | — | WO | claimed |
| EP-2183217-A2 | GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | Boehringer Ingelheim International GmbH (DE) | 2010-05-12 | — | — | EP | claimed |
| EP-2170805-A2 | METHODS OF SYNTHESIZING CINACALCET AND SALTS THEREOF | Amgen Inc. (US) | 2010-04-07 | — | — | EP | claimed |
| US-7674842-B2 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION (US) | 2010-03-09 | — | — | US | claimed |
| US-7572845-B2 | Phase change inks | XEROX CORPORATION (US) | 2009-08-11 | — | — | US | claimed |
| US-20040215002-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040215038-A1 | Colorant precursor compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040215022-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040214918-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-6790267-B1 | METHINE COLORANT COMPOUNDS FOR PHASE CHANGE INKS | XEROX CORPORATION | 2004-09-14 | — | — | US | claimed |
| US-20040167249-A1 | Phase change inks with isocyanate-derived antioxidants and UV stabilizers | XEROX CORPORATION | 2004-08-26 | — | — | US | claimed |
| US-6764541-B1 | Colorant compositions | XEROX CORPORATION | 2004-07-20 | — | — | US | claimed |
| US-6652635-B2 | Cyan phase change inks | XEROX CORPORATION | 2003-11-25 | — | — | US | claimed |
| US-20030079645-A1 | Cyan phase change inks | XEROX CORPORATION | 2003-05-01 | — | — | US | claimed |
| EP-0566567-A1 | ANTIHYPERTENSIVE BENZOPYRAN DERIVATIVES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1993-10-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040215022-A1 | Colorant compositions | ARSA, TST, IK | CYP1A2 1975/4885CYP2C19 2370/4885CYP2D6 2518/4885 |
| US-20040215038-A1 | Colorant precursor compositions | RB1, SULT1A1, CBR1 | CYP1A2 87/4885CYP2C19 805/4885CYP2D6 662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.